• Careers
    • Open Positions
    • Postdoctoral Training
    • Postdoctoral Association
    • Internships
  • Contact
    • Media Inquiries
  • Intranet
La Jolla Institute for Immunology
  • Research
    • Databases
      • Database of Immune Cell Epigenomics
      • Immune Epitope Database
    • Diseases (A-Z)
    • Licensing Opportunities
    • Initiatives
    • Publications
    • Research Centers
      • Center for Autoimmunity and Inflammation
      • Center for Cancer Immunotherapy
      • Center for Infectious Disease and Vaccine Research
    • Research Services
      • Bioinformatics
      • Clinical Studies
      • Cryo-EM
      • DLAC
      • Flow Cytometry
      • Histopathology
      • Microscopy & Histology
      • Next Generation Sequencing
    • Legal Affairs & IP
  • Labs
    • Ay Lab
    • Benedict Lab
    • Cheroutre Lab
    • Croft Lab
    • Crotty Lab
    • Grifoni Lab
    • Hedrick Lab
    • Hogan Lab
    • Kawakami Lab
    • Kronenberg Lab
    • Ley Lab
    • Lindestam Arlehamn Lab
    • Myers Lab
    • Peters Lab
    • Rao Lab
    • Saphire Lab
    • Schoenberger Lab
    • Sette Lab
    • Seumois Lab
    • Sharma Lab
    • Shresta Lab
    • Vijayanand Lab
    • von Herrath Lab
    • Weiskopf Lab
  • News
    • Blog
    • Life Without Disease STORIES
    • Magazine
    • News
    • Videos
  • Events
    • Art Competition
    • Life Without Disease Event Series
    • Live from the Lab
    • Scientific Seminars
  • About Us
    • Overview
      • History
      • Institute Facts
    • Our Team
      • Leadership
      • Faculty
        • Emeriti
        • Clinical Associates
      • Board of Directors
      • Scientific Advisory Board
    • Statements
      • LJI Diversity and Inclusion Statement
      • Vaccines
  • Support
    • Overview
    • Giving Opportunities
      • The Tullie and Rickey Families SPARK Program
      • Center for Precision Immunotherapy
      • Together for Asthma
      • SURGE Program
    • Ways to Give
    • Vanguard Giving Society
    • Planned Giving
    • CARES Act
    • Advancement Team
    • Clinical Studies
    • DONATE
  • Careers
    • Open Positions
    • Postdoctoral Training
    • Postdoctoral Association
    • Internships
  • Contact
    • Media Inquiries
Support

Publications

Reset
Nov 1, 2022 Clin Immunol.
Liraglutide protects β-cells in novel human islet spheroid models of type 1 diabetes
Yesildag B, Mir-Coll J, Neelakandhan A, Gibson CB, Perdue NR, Rufer C, Karsai M, Biernath A, Forschler F, Jin PW, Misun PM, Title A, Hierlemann A, Kreiner FF, Wesley JD, von Herrath MG.
Aug 1, 2022 Curr Opin Endocrinol Diabetes Obes.
Induction of antigenic immune tolerance to delay type 1 diabetes – challenges for clinical translation
Wesley JD, Pagni PP, Bergholdt R, Kreiner FF, von Herrath M.
Aug 1, 2022 Clin Immunol.
Effect of IL4 and IL10 on a human in vitro type 1 diabetes model
Pfeiffer SEM, Quesada-Masachs E, McArdle S, Zilberman S, Yesildag B, Mikulski Z, von Herrath M.
Apr 1, 2022 Expert Rev Clin Immunol.
Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives
Kreiner FF, Kraaijenhof JM, von Herrath M, Hovingh GKK, von Scholten BJ.
Feb 1, 2022 Diabetologia
Upregulation of HLA class II in pancreatic beta cells from organ donors with type 1 diabetes
Quesada-Masachs E, Zilberman S, Rajendran S, Chu T, McArdle S, Kiosses WB, Lee JM, Yesildag B, Benkahla MA, Pawlowska A, Graef M, Pfeiffer S, Mikulski Z, von Herrath M.
Nov 2, 2021 Proc Natl Acad Sci U S A.
How benign autoimmunity becomes detrimental in type 1 diabetes.
von Herrath M, Bonifacio E.
Sep 1, 2021 J Autoimmun.
IL-17 is expressed on beta and alpha cells of donors with type 1 and type 2 diabetes.
Rajendran S, Quesada-Masachs E, Zilberman S, Graef M, Kiosses WB, Chu T, Benkahla MA, Lee JM, von Herrath M.
Aug 13, 2021 Diabetes.
Multicomponent plasmid protects mice from spontaneous autoimmune diabetes.
Pagni PP, Chaplin J, Wijaranakula M, Wesley JD, Granger J, Cracraft J, O'Brien C, Perdue N, Kumar V, Li S, Ratliff SS, Roach A, Misquith A, Chan CL, Coppieters K, von Herrath M.
Aug 1, 2021 Curr Opin Endocrinol Diabetes Obes.
Current state of antigen-specific immunotherapy for type 1 diabetes.
Kreiner FF, von Scholten BJ, Coppieters K, von Herrath M.
Jul 11, 2021 Clin Transl Immunology.
Peripheral autoreactive CD8 T-cell frequencies are too variable to be a reliable predictor of disease progression of human type 1 diabetes.
Wesley JD, Pfeiffer S, Schneider D, Friedrich D, Perdue N, Sehested-Hansen B, Hagopian W, von Herrath MG.
Jun 16, 2021 Front Immunol.
Means, motive, and opportunity: do non-islet-reactive infiltrating T cells contribute to autoimmunity in type 1 diabetes?
Rodriguez-Calvo T, Christoffersson G, Bender C, von Herrath MG, Mallone R, Kent SC, James EA.
May 1, 2021 J Autoimmun.
HLA class I hyper-expression unmasks beta cells but not alpha cells to the immune system in pre-diabetes.
Benkahla MA, Sabouri S, Kiosses WB, Rajendran S, Quesada-Masachs E, von Herrath MG.
  • 1
  • 2
  • 3
  • 4
  • …
  • 10
  • 11
  • 12
  • Contact Us
  • Careers
  • Terms & Conditions
  • Privacy Policy
La Jolla Institute for Immunology

contact@lji.org
9420 Athena Circle
La Jolla, CA 92037

Phone: +1 (858) 752-6500

© 2020 La Jolla Institute for Immunology. All rights reserved.LJI is a 501(c)3 tax-exempt organization.Federal Tax ID Number 33-0328688









 

Designed and Developed by Creative Science Labs

Location: